An AllTrials project

NCT02732899: A reported trial by Maturi, Raj K., M.D., P.C.

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT02732899
Title Sirolimus in Conjunction With EYLEA® (Aflibercept) Versus EYLEA® Alone for Exudative AMD
Results Status Reported
ACT or pACT? This is what FDAAA officially calls a "probable Applicable Clinical Trial"
Start date April 30, 2016
Completion date March 20, 2017
Required reporting date March 20, 2018, midnight
Actual reporting date June 20, 2017
Date last checked at ClinicalTrials.gov May 16, 2025
Days late None